Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News Feature
  • Published:

The second wave in kinase cancer drugs

Cancer drugs targeting signaling pathways have been hampered by problems of efficacy and tumor resistance. Will the next generation of kinase inhibitors fare better than the first? Ken Garber investigates.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Daub H. et al. Nat. Rev. Drug Discov. 3, 1001–1010 (2004).

    Article  CAS  Google Scholar 

  2. McInnes C. et al. Curr. Pharm. Des. 11, 1845–1863 (2005).

    Article  CAS  Google Scholar 

  3. Branca, M. Nat. Biotechnol. 23, 639 (2005).

    Article  CAS  Google Scholar 

  4. Manning G. et al. Science 298, 1912–1934 (2002).

    Article  CAS  Google Scholar 

  5. Krause D.S. et al. New Engl. J. Med. 353, 172–187 (2005).

    Article  CAS  Google Scholar 

  6. Lynch, T.J. et al. New Engl. J. Med. 350, 2129–2139 (2004).

    Article  CAS  Google Scholar 

  7. Paez, J.G. et al., Science, 304, 1497–1500 (2004).

    Article  CAS  Google Scholar 

  8. Neshat, M.S. et al., Proc Natl Acad Sci USA, 98: 10314–10319 (2001).

    Article  CAS  Google Scholar 

  9. Podsypanina, K., et al., Proc Natl Acad Sci USA, 98: 10320–10325 (2001).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Related links

Related links

Related links in Nature Research

Nature Biotechnology 24, 119, (Feb 2006)

Nature Biotechnology 22, 15-18 (Jan 2004)

Nature Biotechnology 23, 267 (Mar 2005

Nature Biotechnology 22, 641 (Jun 2004)

Web links

Onyx Pharmaceuticals

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garber, K. The second wave in kinase cancer drugs. Nat Biotechnol 24, 127–130 (2006). https://doi.org/10.1038/nbt0206-127

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0206-127

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing